 |
What we do
We apply rigorous scientific methods to create coherent,
objective and practical formulary decision models, pharmaceutical
and drug delivery market entry strategies, and healthcare policy recommendations.
Our clients include Pharmaceutical and Biotech Companies, Managed
Care Organizations, and Advocacy Groups.
|
| |
|
| |
Dr. Cheryl
Hankin
is the Co-Founder, President, and Chief Scientific Officer of BioMedEcon
Group.
She received her Ph.D. in Clinical Psychology, with Postdoctoral Fellowships
in Health Services Research and Geropsychology; she completed her
undergraduate degree at Wellesley College, where she earned highest
academic honors as a Wellesley College Scholar.
Dr. Hankin's experience in Health Economics and Outcomes Research
spans the Pharmaceutical Industry (Director of Outcomes Research at
Johnson and Johnson), academia (Assistant Professor at Boston University
School of Public Health), and the public sector (Research Health Scientist
at the Department of Veterans Affairs, Health Services Research and
Development Center of Excellence).
She provides expertise in the following fields: Strategic Product
Positioning for Formulary Acceptance, Pharmacoeconomic Modeling and
Analysis, Health-Related Quality of Life Assessment, Research Design,
and Statistical Analysis. |
|
